In PCOS studies, troxerutin troxerutin has been shown to attenuate dihydrotestosterone-induced insulin resistance in rats by inhibiting IL-22/JAK1/STAT3 signaling activation (55). This evidence concerns the gene STAT3 and Insulin resistance.